human | Q5 |
P496 | ORCID iD | 0000-0001-6226-8270 |
P1053 | ResearcherID | C-3044-2008 |
P108 | employer | University of Edinburgh | Q160302 |
NHS Lothian | Q6954149 | ||
P734 | family name | Reynolds | Q14648920 |
Reynolds | Q14648920 | ||
Reynolds | Q14648920 | ||
P735 | given name | Rebecca | Q503607 |
Rebecca | Q503607 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q60625598 | 127. The Epigenetic Clock at Birth: Associations With Maternal Antenatal Depression and Child Psychiatric Problems |
Q37428328 | A role for kisspeptins in pregnancy: facts and speculations |
Q39479791 | ABCC1 confers tissue-specific sensitivity to cortisol versus corticosterone: A rationale for safer glucocorticoid replacement therapy |
Q60625653 | Additive effects of maternal depressive symptoms during pregnancy and three years after childbirth on offspring psychiatric symptoms in early childhood |
Q50265107 | Altered maternal hypothalamic-pituitary-adrenal axis activity in obese pregnancy is associated with macrosomia and prolonged pregnancy. |
Q96305028 | An evaluation of the benefits and harms of antenatal corticosteroid treatment for women at risk of imminent preterm birth or prior to elective Caesarean-section: Study protocol for an individual participant data meta-analysis |
Q34277852 | An unbalanced maternal diet in pregnancy associates with offspring epigenetic changes in genes controlling glucocorticoid action and foetal growth |
Q61415540 | Antenatal Glucocorticoid Treatment: Are We Doing Harm to Term Babies? |
Q61415534 | Antenatal glucocorticoid treatment for preterm birth: considerations for the developing foetus |
Q98199960 | Approaches to screening for hyperglycaemia in pregnant women during and after the COVID-19 pandemic |
Q46887067 | Assessing the HPA axis in patients with pituitary disease: a UK survey |
Q37331174 | Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study |
Q33688605 | Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study |
Q34413727 | Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes |
Q60625634 | Associations between antenatal glucocorticoid treatment and child psychiatric problems at 3.5 years of age |
Q60625654 | Associations between maternal anxiety symptoms during and three years after pregnancy and child's behavioral symptoms of attention deficit hyperactivity disorder |
Q57671236 | Associations between maternal level of education and occupational status with placental glucocorticoid regeneration and sensitivity |
Q33651669 | Associations between maternal risk factors of adverse pregnancy and birth outcomes and the offspring epigenetic clock of gestational age at birth |
Q114231529 | Associations between parental type 2 diabetes risk and offspring birthweight and placental weight: a survival analysis using the Walker cohort |
Q91246279 | Associations of antenatal glucocorticoid exposure with mental health in children |
Q47381133 | Associations of mood symptoms with ante- and postnatal weight change in obese pregnancy are not mediated by cortisol |
Q38902563 | Brain Development in Fetuses of Mothers with Diabetes: A Case-Control MR Imaging Study |
Q40218353 | Can cortisol predict the future in obesity? |
Q26828897 | Changes in the maternal hypothalamic-pituitary-adrenal axis in pregnancy and postpartum: influences on maternal and fetal outcomes |
Q50755417 | Changing trends in incidence and mortality of thyroid cancer in Scotland. |
Q37106524 | Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study |
Q37832122 | Cognitive function, dementia and type 2 diabetes mellitus in the elderly |
Q52847614 | Cohort Profile: Prediction and prevention of preeclampsia and intrauterine growth restriction (PREDO) study. |
Q115119164 | Cohort profile for the STratifying Resilience and Depression Longitudinally (STRADL) study: A depression-focused investigation of Generation Scotland, using detailed clinical, cognitive, and neuroimaging assessments |
Q46164651 | Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men. |
Q92865602 | Consequences of being overweight or obese during pregnancy on diabetes in the offspring: a record linkage study in Aberdeen, Scotland |
Q36109241 | Convergence in insulin resistance between very severely obese and lean women at the end of pregnancy. |
Q52673038 | Corrigendum: Dynamic Changes in DNA Methylation Occur during the First Year of Life in Preterm Infants. |
Q37684346 | Corticosteroid-mediated programming and the pathogenesis of obesity and diabetes |
Q51295940 | Decreased maternal hypothalamic-pituitary-adrenal axis activity in very severely obese pregnancy: Associations with birthweight and gestation at delivery. |
Q51931004 | Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia. |
Q38713682 | Determinants of cortisol during pregnancy - The ABCD cohort |
Q49548028 | Developmental origins of health and disease: current knowledge and potential mechanisms |
Q34237709 | Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study |
Q61415549 | Differences in cortisol concentrations in South Asian and European men living in the United Kingdom |
Q38715124 | Does attendance at a specialist antenatal clinic improve clinical outcomes in women with class III obesity compared with standard care? A retrospective case-note analysis. |
Q41837216 | Dynamic Changes in DNA Methylation Occur during the First Year of Life in Preterm Infants |
Q114052424 | ENDOCRINOLOGY IN PREGNANCY: Targeting metabolic health promotion to optimise maternal and offspring health |
Q36355726 | Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial |
Q34981504 | Efficacy of metformin in pregnant obese women: a randomised controlled trial. |
Q37677063 | Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study |
Q57671143 | Epigenetic clock at birth and psychiatric problems during early childhood |
Q61415535 | Evaluation of an FFQ to assess total energy and nutrient intakes in severely obese pregnant women |
Q53139827 | Evaluation of kisspeptin levels in obese pregnancy as a biomarker for pre-eclampsia. |
Q57300206 | Fetal programming of neuropsychiatric disorders by maternal pregnancy depression: a systematic mini review |
Q28540611 | Genome wide association identifies common variants at the SERPINA6/SERPINA1 locus influencing plasma cortisol and corticosteroid binding globulin |
Q34678968 | Genome-wide associations for birth weight and correlations with adult disease |
Q42239169 | Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial. |
Q30569967 | Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner |
Q35926504 | Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study |
Q41581839 | Glucocorticoids are lower at delivery in maternal, but not cord blood of obese pregnancies |
Q35376353 | Glucocorticoids turn over slowly in human adipose tissue in vivo |
Q36246730 | Health Behaviours during Pregnancy in Women with Very Severe Obesity |
Q42322088 | Histograms of Oriented 3D Gradients for Fully Automated Fetal Brain Localization and Robust Motion Correction in 3 T Magnetic Resonance Images |
Q36266368 | Hyponatraemia for the clinical endocrinologist |
Q48605538 | ISPNE Special Issue Editorial 2016 Stress and the Brain: From Fertility to Senility |
Q101141242 | Impact of Routine Clinic Measurement of Serum C-Peptide in People with a Clinician-Diagnosis of Type 1 Diabetes |
Q37766390 | Impact of maternal obesity on offspring obesity and cardiometabolic disease risk |
Q39373152 | Impact of maternal steroids during pregnancy |
Q43895004 | Increased maternal BMI is associated with an increased risk of minor complications during pregnancy with consequent cost implications. |
Q48626481 | Increased maternal BMI is associated with infant wheezing in early life: a prospective cohort study. |
Q48945373 | Increased morning adrenocorticotrophin hormone (ACTH) levels in women with postpartum thoughts of harming the infant |
Q28540093 | Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis |
Q30244536 | Influence of maternal obesity on the long-term health of offspring |
Q64996158 | Integrated analysis of environmental and genetic influences on cord blood DNA methylation in new-borns. |
Q47178681 | Intergenerational Transmission of Birth Weight Across Three Generations. |
Q45298892 | Is there a gender difference in the associations of birthweight and adult hypothalamic-pituitary-adrenal axis activity? |
Q91142484 | Is there an increased risk of perinatal mental disorder in women with gestational diabetes? A systematic review and meta-analysis |
Q58853650 | Kisspeptin-10 Inhibits Angiogenesis in Human Placental Vesselsex Vivoand Endothelial Cellsin Vitro |
Q48768927 | Leptin levels and depressive symptoms in people with type 2 diabetes: the edinburgh type 2 diabetes study |
Q44315376 | Leptin, somatic depressive symptoms and the metabolic syndrome: a comment on Chirinos et al. |
Q43191661 | Low serum cortisol predicts early death after acute myocardial infarction |
Q61415542 | Lower maternal socioeconomic position increases placental glucocorticoid sensitivity and transfer |
Q39848427 | Maternal BMI, parity, and pregnancy weight gain: influences on offspring adiposity in young adulthood. |
Q47848836 | Maternal Depressive Symptoms During and After Pregnancy and Psychiatric Problems in Children |
Q47809367 | Maternal Licorice Consumption During Pregnancy and Pubertal, Cognitive, and Psychiatric Outcomes in Children |
Q41359562 | Maternal Obesity During Pregnancy Associates With Premature Mortality and Major Cardiovascular Events in Later Life |
Q46271694 | Maternal and fetal genetic contribution to gestational weight gain. |
Q102334433 | Maternal cortisol is associated with neonatal amygdala microstructure and connectivity in a sexually dimorphic manner |
Q92788374 | Maternal depression and inflammation during pregnancy |
Q57671200 | Maternal depression during pregnancy and epigenetic age in their newborns: The PREDO study |
Q60625643 | Maternal depression during pregnancy is associated with child ADHD symptoms at 3.5years |
Q52581060 | Maternal depressive symptoms during and after pregnancy and child developmental milestones. |
Q47561888 | Maternal depressive symptoms during and after pregnancy are associated with attention-deficit/hyperactivity disorder symptoms in their 3- to 6-year-old children |
Q40814235 | Maternal depressive symptoms during pregnancy, placental expression of genes regulating glucocorticoid and serotonin function and infant regulatory behaviors |
Q39047576 | Maternal depressive symptoms throughout pregnancy are associated with increased placental glucocorticoid sensitivity. |
Q48081027 | Maternal distress associates with placental genes regulating fetal glucocorticoid exposure and IGF2: Role of obesity and sex. |
Q92076069 | Maternal early pregnancy body mass index and diurnal salivary cortisol in young adult offspring |
Q47555270 | Maternal early pregnancy obesity and depressive symptoms during and after pregnancy |
Q60561611 | Maternal early pregnancy obesity and related pregnancy and pre-pregnancy disorders: associations with child developmental milestones in the prospective PREDO Study |
Q39770923 | Maternal gestational weight gain and offspring's risk of cardiovascular disease and mortality |
Q41207534 | Maternal lipids in pregnancy are associated with increased offspring cortisol reactivity in childhood |
Q37248206 | Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1 323 275 person years |
Q61415536 | Metabolic parameters associated with arterial stiffness in older adults with Type 2 diabetes |
Q33751423 | Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study |
Q36720490 | Mutations in HNF1A result in marked alterations of plasma glycan profile |
Q57285914 | Neonatal regulatory behavior problems are predicted by maternal early pregnancy overweight and obesity: findings from the prospective PREDO Study |
Q38237780 | Nick Hales Award Lecture 2011: glucocorticoids and early life programming of cardiometabolic disease |
Q45402850 | Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study |
Q92973485 | Persistently High Levels of Maternal Antenatal Inflammation Are Associated With and Mediate the Effect of Prenatal Environmental Adversities on Neurodevelopmental Delay in the Offspring |
Q48633526 | Physical activity and hypothalamic-pituitary-adrenocortical axis function in adolescents |
Q38964489 | Physical activity in pregnant women with Class III obesity: A qualitative exploration of attitudes and behaviours |
Q36214670 | Placental 5-methylcytosine and 5-hydroxymethylcytosine patterns associate with size at birth |
Q47555616 | Placental Morphology Is Associated with Maternal Depressive Symptoms during Pregnancy and Toddler Psychiatric Problems |
Q46328759 | Placental structure and inflammation in pregnancies associated with obesity. |
Q60561623 | Polygenic risk score of SERPINA6 / SERPINA1 associates with diurnal and stress-induced HPA axis activity in children |
Q44449204 | Predicting cardiovascular risk factors from plasma cortisol measured during oral glucose tolerance tests |
Q50592692 | Prenatal exposure to maternal very severe obesity is associated with impaired neurodevelopment and executive functioning in children. |
Q47802160 | Prenatal exposure to very severe maternal obesity is associated with adverse neuropsychiatric outcomes in children. |
Q36086108 | Prescribing Exercise and Lifestyle Training for High Risk Women in Pregnancy and Early Post-partum-Is It Worth It? |
Q61415544 | Prevalence and markers of advanced liver disease in type 2 diabetes |
Q61415545 | Prevalence of abnormal plasma liver enzymes in older people with Type 2 diabetes |
Q35043760 | Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study |
Q38110738 | Programming effects of glucocorticoids |
Q46043765 | Programming of hypertension: associations of plasma aldosterone in adult men and women with birthweight, cortisol, and blood pressure |
Q47190992 | Pulsatility of Glucocorticoid Hormones in Pregnancy: Changes with Gestation and Obesity. |
Q39495334 | Quantitative analysis of RU38486 (mifepristone) by HPLC triple quadrupole mass spectrometry |
Q34268843 | Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo |
Q38755939 | Reproductive dysfunction and associated pathology in women undergoing military training. |
Q60561629 | Räikkönen et al. Respond to “Maternal Stress and Offspring Health” |
Q41726411 | Screening and management of gestational diabetes mellitus in Scottish obstetric units: a national survey |
Q38469617 | Second primary cancers in thyroid cancer patients: a multinational record linkage study |
Q37705003 | Sedentary behaviours during pregnancy: a systematic review |
Q50762680 | Serum leptin and cognitive function in people with type 2 diabetes. |
Q47634365 | Sex differences in early-life programming of the hypothalamic-pituitary-adrenal axis in humans |
Q39095365 | Sex differences in early-life programming of the hypothalamic-pituitary-adrenal axis in humans suggest increased vulnerability in females: a systematic review. |
Q39284021 | Sex in basic research: concepts in the cardiovascular field |
Q28547479 | Sex-Differences in the Metabolic Health of Offspring of Parents with Diabetes: A Record-Linkage Study |
Q99568247 | Short- and long-term outcomes of gestational diabetes and its treatment on fetal development |
Q89840456 | Sleep disordered breathing in pregnancy: A review of the pathophysiology of adverse pregnancy outcomes |
Q48426661 | Stress biomarkers as predictors of transition to psychosis in at-risk mental states: roles for cortisol, prolactin and albumin |
Q48251882 | Stress responsiveness in adult life: influence of mother's diet in late pregnancy |
Q35921440 | The Association between Maternal 25-Hydroxyvitamin D Concentration during Gestation and Early Childhood Cardio-metabolic Outcomes: Is There Interaction with Pre-Pregnancy BMI? |
Q60561624 | The Epigenetic Clock at Birth: Associations With Maternal Antenatal Depression and Child Psychiatric Problems |
Q37924338 | The consequences of obesity and excess weight gain in pregnancy |
Q38551370 | The effect of fetal growth and nutrient stresses on steroid pathways |
Q60561607 | The epigenetic clock and pubertal, neuroendocrine, psychiatric, and cognitive outcomes in adolescents |
Q35358986 | The postprandial rise in plasma cortisol in men is mediated by macronutrient-specific stimulation of adrenal and extra-adrenal cortisol production |
Q37333381 | The relationship between type 2 diabetes and dementia |
Q38046263 | The risk of maternal obesity to the long-term health of the offspring |
Q37473491 | The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies |
Q53081049 | The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy. |
Q46533300 | The utility of three different methods for measuring urinary 18-hydroxycortisol in the differential diagnosis of suspected primary hyperaldosteronism. |
Q47327241 | Transfer and Metabolism of Cortisol by the Isolated Perfused Human Placenta |
Q92610581 | Transforming mental well-being for people with diabetes: research recommendations from Diabetes UK's 2019 Diabetes and Mental Well-Being Workshop |
Q39394347 | Transmitting biological effects of stress in utero: implications for mother and offspring |
Q39307906 | Unhealthy lifestyle in early psychoses: the role of life stress and the hypothalamic-pituitary-adrenal axis |
Q38989542 | Validity of recalled v. recorded birth weight: a systematic review and meta-analysis |
Q57954646 | Variably methylated regions in the newborn epigenome: environmental, genetic and combined influences |
Q27311571 | Web-based interventions for prevention and treatment of perinatal mood disorders: a systematic review |
Q61415538 | Weight management guides for pregnant women with a body mass index (BMI) ≥ 40kg/m2: A qualitative exploration of their use in maternity care |
Q38078455 | What is the evidence in humans that DNA methylation changes link events in utero and later life disease? |
Search more.